À retenir
In a review of 9 randomized trials (6 in the meta-analysis), low-glycaemic-index (low-GI) diets lowered HbA1c and fasting blood glucose in type 2 diabetes versus higher-GI or control diets (both P < 0.001 for HbA1c). Individual trials were mixed, with no significant HbA1c difference in four studies, and the abstract gives no pooled effect size.
Study design
Méta-analyse d’essais
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Low-GI diets are proposed for managing blood glucose in diabetes, but trials disagree and long-term use is unclear. The authors reviewed randomized trials of low-GI diets in people with type 2 diabetes.
Population et méthode
Systematic review and meta-analysis of randomized controlled trials published between 2008 and 2018 in adults with type 2 diabetes, selected through PubMed, EBSCOHost and grey literature using the PICOS framework. Gestational and type 1 diabetes and observational studies were excluded. Nine articles entered the systematic review and 6 the meta-analysis. Quality, risk of bias, heterogeneity and sensitivity were assessed with Review Manager 5.3.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1HbA1c improved significantly in two studies: low-GI diet -0.5% (95% CI -0.61% to -0.39%) versus high-cereal fibre diet -0.18% (95% CI -0.29% to -0.07%); and low-GI legume diet -0.5% (95% CI -0.6% to -0.4%) versus high-wheat fibre diet -0.3% (95% CI -0.4% to -0.2%).
- 2One study showed a slight improvement (6.5% versus 6.6% in controls), and four studies found no significant difference in HbA1c (P > 0.05).
- 3Four studies reported better fasting glucose on low-GI diets, though results varied: 127.7 versus 136.8 mg/dL (P = 0.02) in one, 7.3 versus 7.7 mmol/L (P < 0.05) in another, and non-significant differences in the other two (P = 0.43 and P > 0.05).
- 4The meta-analysis found significant differences favoring low-GI diets for HbA1c (P < 0.001, and P < 0.001 in sensitivity tests) and for fasting blood glucose (P < 0.05).
Limites et incertitude
- 1Only 6 trials were pooled and the abstract does not report the pooled effect sizes, confidence intervals or heterogeneity, so the size of the benefit is unclear.
- 2The comparators varied (higher-GI, high-fibre, standard diabetic or conventional exchange diets), so the pooled comparison mixes different alternatives.
- 3Individual results were inconsistent, including four studies with no significant HbA1c difference, which tempers the confident conclusion.
- 4Only trials from 2008 to 2018 were included, and this reading is based on the abstract only.
Mise en perspective
Choosing low-GI foods may modestly help blood glucose control in type 2 diabetes, but the evidence is mixed and the benefit size is not stated here. Diet changes for diabetes should be made with a clinician or dietitian, especially for people on glucose-lowering medicine.
Vos données
A continuous glucose monitor, finger-prick log or food diary can show how a meal responds, but HbA1c in these trials reflects months of control. Compare similar meals at similar times with the same meter, and look at trends over weeks rather than single readings.
Comprendre ce type de preuve
Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
The increasing prevalence of diabetes in the United Kingdom and worldwide calls for new approaches to its management, and diets with low glycaemic index have been proposed as a useful means for managing glucose response. However, there are conflicting reports and differences in the results of studies in terms of their effectiveness. Furthermore, the impact of low-glycaemic index diets and their long-term use in patients with type 2 diabetes remains unclear.
Objectives
The objective of this study was to conduct a systematic review and meta-analysis of the effect of low-glycaemic index diets in patients with type 2 diabetes.
Methods
Search methods: Randomised controlled studies were selected from a number of databases (EBSCOHost with links to Health Research databases, PubMed, and grey literature) based on the Population, Intervention, Comparator, Outcomes and Study designs (PICOS) framework. The search terms included synonyms and Medical Subject Headings (MeSH) and involved the use of Boolean operators (AND/OR) which allowed the combination of words and search terms.
Selection criteria
As per the selection criteria, the following types of articles were selected: studies on randomised controlled trials, with year of publication between 2008 and 2018, including patients with type 2 diabetes. Thus, studies involving patients with gestational and type 1 diabetes were excluded, as were observational studies. Nine articles which met the inclusion criteria were selected for the systematic review, whereas only six articles which met the criteria were included in the meta-analysis.
Data collection and analysis
Studies were evaluated for quality and risk of bias. In addition, heterogeneity, meta-analysis, and sensitivity tests of the extracted data were carried out using Review Manager 5.3 (Review Manager, 2014).
Results
The findings of the systematic review showed that the low-glycaemic index (low-GI) diet resulted in a significant improvement (<0.05) in glycated haemoglobin (HbA1c) in two studies: low-GI diet Δ = -0.5% (95% CI, -0.61% to -0.39%) vs. high-cereal fibre diet Δ = -0.18% (95% CI, -0.29% to -0.07%); and low-GI legume diet Δ = -0.5% (95%, -0.6% to -0.4%) vs. high-wheat fibre diet Δ = -0.3% (95% Cl, -0.4 to -0.2%). There was a slight improvement in one study (low glycaemic response = 6.5% (6.3-7.1) vs. control = 6.6% (6.3-7.0) and no significant difference ( p > 0.05) in four studies compared with the control diet. Four studies showed improvements in fasting blood glucose in low-GI diets compared to higher-GI diets or control: low-GI diet = 150.8 ± 8.7 vs. higher-GI diet = 157.8 ± 10.4 mg/dL, mean ± SD p = 0.43; low-GI diet = 127.7 vs. high-cereal fibre diet = 136.8 mg/dL, p = 0.02; low-GI diet = 6.5 (5.6-8.4) vs. standard diabetic diet = 6.7 (6.1-7.5) mmol/L, median and interquartile range p > 0.05; and low-GI diet = 7.3 ± 0.3 vs. conventional carbohydrate exchange diet = 7.7 ± 0.4 mmol/L, mean ± SEM (Standard Error of Mean) p < 0.05. The results of the meta-analysis and sensitivity tests demonstrated significant differences ( p < 0.001 and p < 0.001, respectively) between the low-GI diet and the higher-GI diet or control diet in relation to glycated haemoglobin. Differences between the low-GI diet and higher-GI diet or control were significant ( p < 0.05) with respect to the fasting blood glucose following meta-analysis.
Conclusion
The low-GI diet is more effective in controlling glycated haemoglobin and fasting blood glucose compared with a higher-GI diet or control in patients with type 2 diabetes.
Sources et attribution
The Effect of Dietary Glycaemic Index on Glycaemia in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ojo O, Ojo OO, Adebowale F, Wang XH.
Nutrients · 2018-03-19
DOI: 10.3390/nu10030373 ↗PubMed · 29562676 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Early time-restricted eating linked to more weight loss and lower insulin than late eating
Pooling 41 randomised trials (2287 participants, median intervention 8 weeks), time-restricted eating was associated with 2.15 kg lower body weight than usual diets (95% CI -2.56 to -1.74), and eating early beat eating late by 1.15 kg (95% CI -1.86 to -0.45). Most trials were short, only 6 study arms tested early eating, and the outcomes were body and blood measures, not heart attacks or deaths.
BMJ Medicine
An 8 a.m. to 4 p.m. eating window added to calorie cutting gave no clear extra weight loss
Among 139 patients with obesity on a calorie-restricted diet, adding an eating window of 8:00 a.m. to 4:00 p.m. led to a mean 12-month weight change of -8.0 kg, versus -6.3 kg with calorie restriction alone. The net difference of -1.8 kg (95% CI -4.0 to 0.4; P = 0.11) was not statistically significant, and the interval cannot rule out either a real benefit or none.
The New England Journal of Medicine
In a 20-person ward trial, an ultra-processed menu led to more eating and weight gain
In 20 adults living in a hospital research unit for 28 days, an ultra-processed menu led them to eat 508 kcal/day more (± 106 SE, P = 0.0001) and gain 0.9 kg, while a menu of unprocessed foods led to a 0.9 kg loss, each over 2 weeks and with eating left to appetite. The study was small, short and fully provisioned, so it cannot show what happens in daily life or which feature of the foods drove the extra eating.
Cell Metabolism
Mediterranean diet with olive oil or nuts linked to fewer heart events (corrected trial)
Among 7447 Spanish adults aged 55 to 80 at high cardiovascular risk, those assigned to a Mediterranean diet with extra-virgin olive oil (HR 0.69, 95% CI 0.53 to 0.91) or with nuts (HR 0.72, 0.54 to 0.95) had fewer major cardiovascular events than those told to cut dietary fat. The trial had randomisation errors, which is why the 2013 report was withdrawn and the estimates recalculated, so treat this as strong but imperfect evidence.
The New England Journal of Medicine

